Author

Thomas Seufferlein

Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline
Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline

Thomas Seufferlein  et al.

FUNCTIONAL GENOMIC SCREENING DURING SOMATIC CELL REPROGRAMMING IDENTIFIES DKK3 AS A ROADBLOCK OF ORGAN REGENERATION
FUNCTIONAL GENOMIC SCREENING DURING SOMATIC CELL REPROGRAMMING IDENTIFIES DKK3 AS A ROADBLOCK OF ORGAN REGENERATION

Thomas Seufferlein  et al.

MODELLING JOHANSON-BLIZZARD SYNDROME IN A DISH
MODELLING JOHANSON-BLIZZARD SYNDROME IN A DISH

Thomas Seufferlein  et al.

DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER
DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER

Thomas Seufferlein  et al.

THE EPIGENETIC FACTOR EZH2 ORCHESTRATES ONCOGENIC FEATURES IN ATM-DEFICIENT PANCREATIC CANCER
THE EPIGENETIC FACTOR EZH2 ORCHESTRATES ONCOGENIC FEATURES IN ATM-DEFICIENT PANCREATIC CANCER

Thomas Seufferlein  et al.

ENDOFUTURE-STRATEGIES FROM CIVIL AVIATION FOR OPTIMIZED TEAMWORK AND COMMUNICATION IN INTERVENTIONAL ENDOSCOPY
ENDOFUTURE-STRATEGIES FROM CIVIL AVIATION FOR OPTIMIZED TEAMWORK AND COMMUNICATION IN INTERVENTIONAL ENDOSCOPY

Thomas Seufferlein  et al.

EXPLORING ROLES OF ATM-DELETION IN PANCREATIC CANCER VULNERABILITIES AND CANCER-ASSOCIATED FIBROBLAST/TUMOR CELL CROSSTALK
EXPLORING ROLES OF ATM-DELETION IN PANCREATIC CANCER VULNERABILITIES AND CANCER-ASSOCIATED FIBROBLAST/TUMOR CELL CROSSTALK

Thomas Seufferlein  et al.

REAL-LIFE EXPERIENCE OF PHARMACOTYPING AND RESPONSE PREDICTION USING PANCREATIC CANCER PATIENT-DERIVED ORGANOIDS
REAL-LIFE EXPERIENCE OF PHARMACOTYPING AND RESPONSE PREDICTION USING PANCREATIC CANCER PATIENT-DERIVED ORGANOIDS

Thomas Seufferlein  et al.

THE TRANSCRIPTION FACTOR TBX3 FOSTERS REGENERATION FROM ACUTE PANCREATITIS AND SHOWS SWITCHING EXPRESSION PATTERNS IN THE EMBRYONIC PANCREAS
THE TRANSCRIPTION FACTOR TBX3 FOSTERS REGENERATION FROM ACUTE PANCREATITIS AND SHOWS SWITCHING EXPRESSION PATTERNS IN THE EMBRYONIC PANCREAS

Thomas Seufferlein  et al.

PARP INHIBITOR RESISTANCE INDUCES MASSIVE GENOME ALTERATIONS RESPONSIBLE OF THE ACQUISITION OF MULTIDRUG RESISTANCE IN DNA DAMAGE REPAIR-DEFICIENT PANCREATIC CANCER
PARP INHIBITOR RESISTANCE INDUCES MASSIVE GENOME ALTERATIONS RESPONSIBLE OF THE ACQUISITION OF MULTIDRUG RESISTANCE IN DNA DAMAGE REPAIR-DEFICIENT PANCREATIC CANCER

Thomas Seufferlein  et al.

MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY
MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY

Thomas Seufferlein  et al.

THE ROLE OF THE TRANSCRIPTION FACTOR TBX3 IN THE EMBRYONIC DEVELOPMENT OF THE MURINE PANCREAS AND REGENERATION OF ACUTE PANCREATITIS
THE ROLE OF THE TRANSCRIPTION FACTOR TBX3 IN THE EMBRYONIC DEVELOPMENT OF THE MURINE PANCREAS AND REGENERATION OF ACUTE PANCREATITIS

Thomas Seufferlein  et al.

TUMORAL STATUS OF ATM DETERMINES CANCER-ASSOCIATED FIBROBLAST CELL FATE IN PANCREATIC DUCTAL ADENOCARCINOMA
TUMORAL STATUS OF ATM DETERMINES CANCER-ASSOCIATED FIBROBLAST CELL FATE IN PANCREATIC DUCTAL ADENOCARCINOMA

Thomas Seufferlein  et al.

TBX3 SHOWS SWITCHING EXPRESSION PATTERNS IN THE EMBRYONIC PANCREAS AND FINE-TUNES REGENERATION FROM ACUTE PANCREATITIS
TBX3 SHOWS SWITCHING EXPRESSION PATTERNS IN THE EMBRYONIC PANCREAS AND FINE-TUNES REGENERATION FROM ACUTE PANCREATITIS

Thomas Seufferlein  et al.

THE PORCINE URINARY BLADDER FUNCTIONS AS AN INNOVATIVE IN VITRO MODEL FOR THE INVESTIGATION OF HUMAN PANCREATIC DEVELOPMENT AND CARCINOGENESIS IN A PLURIPOTENT STEM CELL-BASED APPROACH
THE PORCINE URINARY BLADDER FUNCTIONS AS AN INNOVATIVE IN VITRO MODEL FOR THE INVESTIGATION OF HUMAN PANCREATIC DEVELOPMENT AND CARCINOGENESIS IN A PLURIPOTENT STEM CELL-BASED APPROACH

Thomas Seufferlein  et al.

ATM AND P53 AUTONOMOUS ROLES DURING PANCREATIC CANCER TUMORIGENESIS
ATM AND P53 AUTONOMOUS ROLES DURING PANCREATIC CANCER TUMORIGENESIS

Thomas Seufferlein  et al.

SELECTIVE ELIMINATION OF CD133+ CANCER STEM CELLS AS THERAPY FOR PDAC USING NOVELDUAL BET/HDAC INHIBITOR TW09
SELECTIVE ELIMINATION OF CD133+ CANCER STEM CELLS AS THERAPY FOR PDAC USING NOVELDUAL BET/HDAC INHIBITOR TW09

Thomas Seufferlein  et al.

KRAS ACTIVATION IN THE CONTEXT OF BRCA2 DEFICIENCY DRIVES DEDIFFERENTIATION OF DUCTAL ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
KRAS ACTIVATION IN THE CONTEXT OF BRCA2 DEFICIENCY DRIVES DEDIFFERENTIATION OF DUCTAL ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

Thomas Seufferlein  et al.

MCCUNE-ALBRIGHT SYNDROME AND IPMN FORMATION MODELLED IN GNAS-MUTATED DUCT-LIKE ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
MCCUNE-ALBRIGHT SYNDROME AND IPMN FORMATION MODELLED IN GNAS-MUTATED DUCT-LIKE ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

Thomas Seufferlein  et al.

MODELLING PLASTICITY AND DYSPLASIA OF PANCREATIC DUCTAL ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
MODELLING PLASTICITY AND DYSPLASIA OF PANCREATIC DUCTAL ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

Thomas Seufferlein  et al.

Item 21 - 40 / 47
1
2
3